Y-Intercept (HK)’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Buy
+16,701
New +$198K ﹤0.01% 1541
2026
Q1
Sell
-44,104
Closed -$357K 1590
2025
Q4
$357K Buy
+44,104
New +$482K 0.01% 1329
2025
Q3
Sell
-73,881
Closed -$964K 1604
2025
Q2
$964K Buy
+73,881
New +$1.02M 0.02% 955
2023
Q3
Sell
-18,451
Closed -$518K 1107
2023
Q2
$518K Buy
+18,451
New +$458K 0.05% 554
2023
Q1
Sell
-12,725
Closed -$338K 1207
2022
Q4
$338K Buy
+12,725
New +$415K 0.05% 598

Other funds holding CCRN

Y-Intercept (HK)'s CCRN Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Cross Country Healthcare (CCRN) in Q2 2026: 16,701 shares worth $221K. The stake represents ﹤0.01% of the portfolio and ranks #1541 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in CCRN as recently as Q4 2025.

Y-Intercept (HK) first reported a position in CCRN in Q4 2022 and has held it in 5 quarters since. The position peaked at $964K in Q2 2025. 19 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • Y-Intercept (HK) held 16,701 shares of Cross Country Healthcare worth $221K as of Q2 2026.
  • Cross Country Healthcare was a new Y-Intercept (HK) position in Q2 2026.
  • Cross Country Healthcare made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1541 holding.
  • Y-Intercept (HK) first reported a position in Cross Country Healthcare in Q4 2022 and has held it in 5 quarters since.
  • Y-Intercept (HK)'s Cross Country Healthcare position peaked at $964K in Q2 2025.
  • 19 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.